Sign in

CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275414423
Phone
(650) 822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. 4 Grant or award EVP & CHIEF SCIENTIFIC OFFICER acquired 44,963 shares (grant or award)
  2. 4 Grant or award CHIEF MEDICAL OFFICER acquired 44,963 shares (grant or award)
  3. 4 Grant or award EVP & CHIEF FINANCIAL OFFICER acquired 44,963 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award EVP & CHIEF INNOVATION OFFICER acquired 44,963 shares (grant or award)
  6. 4 Grant or award EVP & CHIEF BUSINESS OFFICER acquired 44,963 shares (grant or award)
  7. 10-K Report Annual Report
  8. 8-K Event Results of operations
  9. 4 Open-market sale CHIEF MEDICAL OFFICER sold 5,521 shares at $2.96 ($16,342)
  10. 4 Open-market sale EVP & CHIEF SCIENTIFIC OFFICER sold 5,515 shares at $2.97 ($16,380)
  11. 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 8,345 shares at $2.91 ($24,284)
  12. 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 6,618 shares at $2.95 ($19,523)
  13. 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 6,912 shares at $2.92 ($20,183)
  14. 4 Open-market sale PRESIDENT AND CEO sold 5,021 shares at $2.95 ($14,812)
  15. 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 1,786 shares at $2.98 ($5,322)
  16. 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 1,425 shares at $2.99 ($4,261)
  17. 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 1,783 shares at $2.99 ($5,331)
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 7 of 27 · 524 filings